← TANDEM DIABETES CARE INC TNDM
Market Price
$22.71
Market Cap
$1.58B
P/E Ratio
N/A
Revenue (FY 2025)
↑7.9% YoY
$1.01B
3-Yr CAGR: 8.2%
Net Income
↓-113.2% YoY
-$204.71M
Net Margin: -20.2%
Free Cash Flow
↓-694.1% YoY
-$29.67M
FCF Yield: -1.87%
EPS (Diluted)
↓-106.8% YoY
$-3.04
Basic: $-3.04
Return on Equity
Efficiency
-131.9%
ROA: -655.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TNDM)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $84.2M | — | $23.6M | $-83.4M | — | — | — | $-61.2M | $-70.1M | — |
| FY 2017 | $107.6M | +27.7% | $44.1M | $-73.0M | +12.5% | — | — | $-66.1M | $-71.9M | -2.5% |
| FY 2018 | $183.9M | +70.9% | $89.8M | $-122.6M | -67.9% | — | — | $-8.3M | $-11.3M | +84.3% |
| FY 2019 | $362.3M | +97.0% | $194.2M | $-24.8M | +79.8% | — | — | $41.9M | $22.4M | +297.8% |
| FY 2020 | $498.8M | +37.7% | $260.5M | $-34.4M | -38.9% | — | — | $24.7M | $-2.7M | -112.2% |
| FY 2021 | $702.8M | +40.9% | $376.2M | $15.6M | +145.3% | $0.24 | — | $111.4M | $97.2M | +3,648.0% |
| FY 2022 | $801.2M | +14.0% | $413.0M | $-94.6M | -707.7% | $-1.47 | -712.5% | $50.5M | $16.4M | -83.2% |
| FY 2023 | $747.7M | -6.7% | $367.7M | $-222.6M | -135.3% | $-3.43 | -133.3% | $-31.8M | $-58.6M | -458.1% |
| FY 2024 | $940.2M | +25.7% | $489.6M | $-96.0M | +56.9% | $-1.47 | +57.1% | $24.2M | $5.0M | +108.5% |
| FY 2025 | $1,014.7M | +7.9% | $546.0M | $-204.7M | -113.2% | $-3.04 | -106.8% | $-9.7M | $-29.7M | -694.1% |
Valuation
Market Price
$22.71
Market Cap
$1.58B
Enterprise Value
$1.80B
P/E Ratio
N/A
P/B Ratio
10.03
FCF Yield
-1.87%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
53.81%
Operating Margin
-18.45%
Net Margin
-20.17%
Return on Equity (ROE)
-131.93%
Return on Assets (ROA)
-655.76%
Asset Turnover
32.51x
Revenue 3-Yr CAGR
8.19%
Financial Health & Liquidity
Current Ratio
1.49
Cash Ratio
4.31
Debt / Equity
1.998
Debt / Assets
9.932
Cash & Equivalents
$90.63M
Total Debt
$310.04M
Book Value / Share
$2.26
Cash Flow Efficiency
Operating Cash Flow
-$9.72M
Capital Expenditures (CapEx)
$19.95M
Free Cash Flow
-$29.67M
OCF / Revenue
-0.96%
FCF / Revenue
-2.92%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-3.04
EPS (Basic)
$-3.04
Dividends / Share
N/A
Book Value / Share
$2.26
EPS YoY Growth
-106.80%
Balance Sheet (FY 2025)
Total Assets
$31.22M
Total Liabilities
$21.01M
Stockholders' Equity
$155.17M
Current Assets
$31.22M
Current Liabilities
$21.01M